By
World Health Organization
Published: Jan. 17, 2023, 7:15 p.m.·
Tags:
Global TB response,
Vaccines,
Advocacy
The Council will facilitate the licensing and use of effective novel TB vaccines catalysing high-level alignment between funders, global agencies, governments and end users in identifying and overcoming barriers to TB vaccine development.
Read More →
By
1/4/6x24 Campaign Coalition,
Treatment Action Group
Published: Jan. 17, 2023, 11:46 a.m.·
Tags:
Treatment,
Access,
Advocacy
A few recent Campaign updates from Treatment Action Group and allies.
Contact david.branigan@treatmentactiongroup.org for more information on how to be part of the 1/4/6x24 Campaign.
Read More →
By
TB advocates
Published: Jan. 16, 2023, 9:36 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Advocates urge Johnson & Johnson to correct its course and stop blocking entry of generic versions of bedaquiline into the global market and into countries.
Read More →
By
Médecins Sans Frontières
Published: Jan. 16, 2023, 6:30 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Médecins Sans Frontières urges the Indian Patent Office to reject the secondary patent application filed by Johnson & Johnson to prevent the company from extending its monopoly on bedaquiline beyond the primary patent’s expiry in July 2023.
Read More →
By
World Health Organization
Published: Dec. 15, 2022, 8:05 p.m.·
Tags:
Drug-resistant TB,
Guidelines
The World Health Organization releases updated guidelines and a supporting operational handbook on the treatment of drug-resistant TB featuring major improvements in treatment options for people with multidrug-resistant or rifampicin-resistant TB.
Read More →
By
Stop TB Partnership
Published: Dec. 14, 2022, 3:19 p.m.·
Tags:
Global TB response,
Advocacy
GFAN is selected to coordinate the Affected Communities and Civil Society Platform for the 2023 UN High-Level Meeting on TB. Applications are now being accepted for lead consultant(s) to support this work (Deadline: 5 January 2023).
Read More →
By
GCTA
Published: Dec. 14, 2022, 3 p.m.·
Tags:
Global TB response,
TB programs,
Advocacy
Innovative TB Community Service Delivery during the COVID-19 Pandemic: Best Practices and Lessons Learned from Cambodia, India, Indonesia, and Kenya
Read More →
By
Stop TB Partnership
Published: Dec. 12, 2022, 3:23 p.m.·
Tags:
Diagnostics,
Guidelines
The manual provides an overview of the recommended use of IGRAs as a class of in-vitro tests for the detection of TB infection and describes their performance, steps for use and implementation considerations.
Read More →
By
World Health Organization
Published: Dec. 8, 2022, 3:59 p.m.·
Tags:
Vaccines,
Research and development
A document summarizes the results of the WHO-commissioned full value proposition for new TB vaccines.
Read More →
By
Treatment Action Group,
Stop TB Partnership
Published: Dec. 6, 2022, 8:32 p.m.·
Tags:
Global TB response,
Research and development
A report highlights that despite reaching US$1 billion in spending in 2021, funding for TB R&D is a mere fraction of what’s needed to achieve UN sustainable development goal of ending TB as a pandemic by 2030.
Read More →
Page 1 of 119 · Total posts: 10
1
2
Last→